Aripiprazole for the management of olanzapine-induced weight gain.
Englisch
S
S
Weinbrenner
A
A
Inta
D
D
Zink
M
M
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000009:adverse effects*; D001835:Body Weight / Q000187:drug effects; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism; D004359:Drug Therapy, Combination; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D015363:Quinolones / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D016896:Treatment Outcome; D014280:Triglycerides / Q000378:metabolism; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D002491:Central Nervous System Agents; D010879:Piperazines; D015363:Quinolones; D014280:Triglycerides; D001569:Benzodiazepines; D000068180:Aripiprazole; D002784:Cholesterol; D005947:Glucose; D000077152:Olanzapine